跳至主導覽 跳至搜尋 跳過主要內容

Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression

  • Chia Cheng Yu
  • , Lih Chyang Chen
  • , Chih Yung Chiou
  • , Yu Jia Chang
  • , Victor C. Lin
  • , Chao Yuan Huang
  • , I. Ling Lin
  • , Ta Yuan Chang
  • , Te Ling Lu
  • , Cheng Hsueh Lee
  • , Shu Pin Huang*
  • , Bo Ying Bao
  • *此作品的通信作者
  • Veterans General Hospital-Kaohsiung Taiwan
  • National Yang Ming Chiao Tung University
  • Tajen University
  • Mackay Memorial Hospital Taiwan
  • Chang Gung Memorial Hospital
  • Taipei Medical University
  • I-Shou University
  • National Taiwan University
  • Kaohsiung Medical University
  • China Medical University Taichung
  • National Sun Yat-sen University
  • Asia University Taiwan

研究成果: 期刊稿件 › 文章 › 同儕審查

31 引文 斯高帕斯(Scopus)

摘要

Background: To determine the association between circadian pathway genetic variants and the risk of prostate cancer progression. Methods: We systematically evaluated 79 germline variants in nine circadian pathway genes in a cohort of 458 patients with localized prostate cancer as the discovery phase. We then replicated the significant findings in another cohort of 324 men with more advanced disease. The association of each variant with prostate cancer progression was evaluated by a log-rank test and Cox regression. Results: A single nucleotide polymorphism of the neuronal PAS domain protein 2 (NPAS2) gene (rs6542993 A>T) was found to be associated with a significantly higher risk of disease progression in both localized (P = 0.001) and advanced (P = 0.039) prostate cancer cases. In silico analysis revealed decreased expression levels of NPAS2 in carriers of the T allele of rs6542993 compared with those carrying the A allele. Consistently, downregulation of NPAS2 expression was associated with more aggressive prostate cancer and poor progression-free survival (log-rank P = 0.002). Conclusions: The NPAS2 rs6542993 polymorphism may be a promising biomarker, and may shed light on the pathways that govern prostate cancer progression.

原文英語
文章編號87
期刊Cancer Cell International
卷19
發行號1
DOIs
出版品狀態已出版 - 05 04 2019
對外發佈是

文獻附註

Publisher Copyright:
© 2019 The Author(s).

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression」主題。共同形成了獨特的指紋。

引用此